Cargando…
Thyrotropin receptor antibodies and Graves’ orbitopathy
CONTEXT AND PURPOSE: The thyrotropin receptor (TSHR) is the key autoantigen in Graves’ disease (GD) and associated orbitopathy (GO). Antibodies targeting the TSHR (TSHR-Ab) impact the pathogenesis and the course of GO. This review discusses the role and clinical relevance of TSHR-Ab in GO. METHODS:...
Autores principales: | Diana, T., Ponto, K. A., Kahaly, G. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310479/ https://www.ncbi.nlm.nih.gov/pubmed/32749654 http://dx.doi.org/10.1007/s40618-020-01380-9 |
Ejemplares similares
-
Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2021) -
Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy
por: George, Augustine, et al.
Publicado: (2021) -
Sensitivity of three thyrotropin receptor antibody assays in thyroid-associated orbitopathy
por: Sarić-Matutinović, Marija, et al.
Publicado: (2022) -
Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease
por: Kahaly, George J, et al.
Publicado: (2019) -
Graves' Orbitopathy
por: Hiromatsu, Yuji, et al.
Publicado: (2015)